Ajinomoto's $546M Acquisition of US-based Forge Biologics
jason tuinstra 4OfaTz6SdYs unsplash

Japan’s Ajinomoto agreed to acquire U.S.-based genetic medicines maker Forge Biologics Holdings for 82.8 billion yen ($546 million).

The transaction is expected to be completed in December 2023 pending regulatory approvals, Ajinomoto said a release.

Ajinomoto, whose primary business is in seasonings and processed foods, has a healthcare segment that focuses on drugs derived from amino acids.

Forge, based in the U.S. state of Ohio, is a contract development and manufacturing organization (CDMO) for gene-based therapies. Ajinomoto said Forge will integrate with its own AminoScience platform to work on new treatment options for rare diseases.

($1 = 151.7400 yen)

Source: Reuters

Related Articles

General, Investors/Business
Information, News
The government and the ruling coalition are planning to extend a tax break system for people who renovate their homes, sources familiar with the matter said. The home renovation tax relief is set to expire at the end of this year but government and ruling coalition officials are considering keeping it in place until the end of 2023, the sources said. The decision to extend the program is aimed at promoting sales of used homes amid a spike in vacant homes across the country.
General
Information
The Kansai region, which includes major cities such as Osaka, Kyoto, Kobe, Nara, and Wakayama, is a vibrant part of Japan with a rich history, dynamic culture, and a diverse economy. Compared to the more hectic Kanto region, Kansai offers a unique blend of modernity and tradition, with a slightly slower pace of life and lower real estate prices.
General
Information, Investment Property
Cheap Japan properties often hide structural, legal, and resale risks. Learn the 5 hidden costs and how to spot genuine real estate opportunities.